Patients’ characteristics
A total of 285 confirmed Covid-19 patients, after initial screening and excluding, were enrolled in the study during two consecutive months of study period, and subdivided in two groups (fig 1).
The baseline characteristics of all enrolled patients are shown in Table 1. As shown in this table, the patients had no significant differences between the two groups regarding the demographic data, baseline characteristics and underlying diseases.
Patient’s comorbidities and underlying diseases, including chronic cardiovascular disease, hypertension, diabetes, chronic pulmonary and kidney disease.
Overall, 117 (41.1%) Patients were female and 168 (58.9%) were male, their ages ranged from 16 to 91 years old (mean=53.80, sd=16.71).
Of these identified cases, 120 patients were classified in group 1 (oselta group), who received oseltamivir plus routine regimen, while 165 patients were classified in group 2 (control group), who were treated with routine regimen alone. The flow chart of current study is shown in figure 1.
The disease severity assessed by NEWS scoring (physicians, 2017) and chest CT scans findings on the admission day (Assistant, 2020), was different between two groups and oselta group had a higher severity score (5.02 vs 4.2, p=0.01) (Table 2).